{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:24:14Z","timestamp":1794925454521,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019652","name":"British University in Egypt","doi-asserted-by":"publisher","award":["2018-16"],"award-info":[{"award-number":["2018-16"]}],"id":[{"id":"10.13039\/501100019652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.biopha.2022.114050","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T04:49:03Z","timestamp":1669783743000},"page":"114050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Elafibranor modulates ileal macrophage polarization to restore intestinal integrity in NASH: Potential crosstalk between ileal IL-10\/STAT3 and hepatic TLR4\/NF-\u03baB axes"],"prefix":"10.1016","volume":"157","author":[{"given":"Andrew N.","family":"Hakeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A.","family":"Tawfiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma A.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat A.","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Elmazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman S.","family":"El-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.114050_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.114050_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.114050_bib3","article-title":"Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability","volume":"1","author":"Luther","year":"2015","journal-title":"CMGH"},{"key":"10.1016\/j.biopha.2022.114050_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.114050_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2022.114050_bib6","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2022.114050_bib7","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"Csak","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2022.114050_bib8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","article-title":"NF-\u03baB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis","volume":"129","author":"Dela Pe\u00f1a","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.114050_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41366-019-0430-0","article-title":"Circulating microbiota-derived metabolites: a \u201cliquid biopsy?","volume":"44","author":"Aragon\u00e8s","year":"2020","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2022.114050_bib10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1572-0241.2004.40009.x","article-title":"Hepatocyte apoptosis, expression of death receptors, and activation of NF-\u03baB in the liver of nonalcoholic and alcoholic steatohepatitis patients","volume":"99","author":"Ribeiro","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.114050_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","article-title":"Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD","volume":"16","author":"Na","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.114050_bib12","doi-asserted-by":"crossref","unstructured":"A. Arranz, C. Doxaki, E. Vergadi, Y.M. De La Torre, K. Vaporidi, E.D. Lagoudaki, E. Ieronymaki, A. Androulidaki, M. Venihaki, A.N. Margioris, E.N. Stathopoulos, P.N. Tsichlis, C. Tsatsanis, Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization, Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 9517\u20139522. https:\/\/doi.org\/10.1073\/pnas.1119038109.","DOI":"10.1073\/pnas.1119038109"},{"key":"10.1016\/j.biopha.2022.114050_bib13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2017.04.036","article-title":"Mitochondrial ROS production protects the intestine from inflammation through functional M2 macrophage polarization","volume":"19","author":"Formentini","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.114050_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2017.01383","article-title":"Toll-like receptor ligands and interferon-\u03b3 synergize for induction of antitumor M1 macrophages","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.114050_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2014.06.020","article-title":"Involvement of nitric oxide with activation of Toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitis","volume":"74","author":"Tun","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.114050_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Ip","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.114050_bib17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jcmgh.2021.07.005","article-title":"The production and function of endogenous interleukin-10 in intestinal epithelial cells and gut homeostasis","volume":"12","author":"Nguyen","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.114050_bib18","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1073\/pnas.0500419102","article-title":"The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription","volume":"102","author":"Murray","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2022.114050_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.114050_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-020-00251-y","article-title":"Metabolic reprogramming in macrophage responses","volume":"9","author":"Liu","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.biopha.2022.114050_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2022.114050_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1152\/physiolgenomics.00198.2006","article-title":"Genome-wide analysis of PPAR\u03b1 activation in murine small intestine","volume":"30","author":"B\u00fcnger","year":"2007","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.biopha.2022.114050_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.intimp.2010.07.007","article-title":"PPAR\u03b1 contributes to colonic protection in mice with DSS-induced colitis","volume":"10","author":"Azuma","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2022.114050_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep05412","article-title":"PPAR\u03b2\/\u03b4 activation of CD300a controls intestinal immunity","volume":"4","author":"Tanaka","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.114050_bib25","doi-asserted-by":"crossref","DOI":"10.3791\/62543","article-title":"A model of experimental steatosis in vitro: hepatocyte cell culture in lipid overload-conditioned medium","author":"Campos-Espinosa","year":"2021","journal-title":"JoVE"},{"key":"10.1016\/j.biopha.2022.114050_bib26","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jhep.2011.02.035","article-title":"DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH","volume":"55","author":"G\u00e4bele","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.114050_bib27","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","article-title":"Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet","volume":"46","author":"Matsuzawa","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.114050_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.114050_bib29","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/jcp.22682","article-title":"Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis","volume":"226","author":"Yazbeck","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2022.114050_bib30","first-page":"463","article-title":"Dextran sulfate sodium induces pan-gastroenteritis in rodents: Implications for studies of colitis","volume":"63","author":"Elsheikh","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.114050_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113136","article-title":"Taurocholic acid, a primary 12\u03b1-hydroxylated bile acid, induces leakiness in the distal small intestine in rats","volume":"165","author":"Liu","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2022.114050_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1208468","article-title":"Intestinal barrier analysis by assessment of mucins, tight junctions, and \u03b1-defensins in healthy C57BL\/6J and BALB\/cJ mice","volume":"4","author":"Volynets","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.biopha.2022.114050_bib33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.114050_bib34","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2022.114050_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J. Histochem. Cytochem"},{"key":"10.1016\/j.biopha.2022.114050_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.114050_bib37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.114050_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10565-020-09544-2","article-title":"Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists","volume":"37","author":"Boeckmans","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.biopha.2022.114050_bib39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.114050_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.114050_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.114050_bib42","doi-asserted-by":"crossref","first-page":"16390","DOI":"10.1074\/jbc.M000953200","article-title":"The acute phase response is associated with retinoid X receptor repression in rodent liver","volume":"275","author":"Beigneux","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.114050_bib43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbadis.2014.03.015","article-title":"Negatively regulating TLR4\/NF-\u03baB signaling via PPAR\u03b1 in endotoxin-induced uveitis","volume":"1842","author":"Shen","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2022.114050_bib44","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2022.114050_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1189\/jlb.3RU0316-151R","article-title":"Endotoxemia-menace, marker, or mistake?","volume":"100","author":"Munford","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2022.114050_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109953","article-title":"Obeticholic acid orchestrates the crosstalk between ileal autophagy and tight junctions in non-alcoholic steatohepatitis: Role of TLR4\/TGF-\u03b21 axis","volume":"361","author":"Tawfiq","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2022.114050_bib47","first-page":"1163","article-title":"Reliability of plasma lipopolysaccharide-binding protein (LBP) from repeated measures in healthy adults","volume":"27","author":"Citronberg","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.biopha.2022.114050_bib48","article-title":"Detoxifying endotoxin: time, place and person","volume":"11","author":"Munford","year":"2005","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.biopha.2022.114050_bib49","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/eji.201343981","article-title":"Arginase activity in alternatively activated macrophages protects PI3Kp110\u03b4 deficient mice from dextran sodium sulfate induced intestinal inflammation","volume":"44","author":"Weisser","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2022.114050_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101879","article-title":"Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase","volume":"41","author":"Rajcic","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2022.114050_bib51","first-page":"1","article-title":"High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.114050_bib52","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1091\/mbc.e05-03-0193","article-title":"Mechanism of IFN-\u03b3-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane","volume":"16","author":"Utech","year":"2005","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.biopha.2022.114050_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.817583","article-title":"l-Isoleucine administration alleviates DSS-induced colitis by regulating TLR4\/MyD88\/NF-\u03baB pathway in rats","volume":"12","author":"Mao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.114050_bib54","doi-asserted-by":"crossref","unstructured":"A. Sapone, L. de Magistris, M. Pietzak, M.G. Clemente, A. Tripathi, F. Cucca, R. Lampis, D. Kryszak, M. Carten\u00ec, M. Generoso, D. Iafusco, F. Prisco, F. Laghi, G. Riegler, R. Carratu, D. Counts, A. Fasano, Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives, Diabetes. 55 (2006) 1443\u20131449. https:\/\/doi.org\/10.2337\/db05\u20131593.","DOI":"10.2337\/db05-1593"},{"key":"10.1016\/j.biopha.2022.114050_bib55","doi-asserted-by":"crossref","unstructured":"L.B. Giron, H. Dweep, X. Yin, H. Wang, M. Damra, A.R. Goldman, N. Gorman, C.S. Palmer, H.Y. Tang, M.W. Shaikh, C.B. Forsyth, R.A. Balk, N.F. Zilberstein, Q. Liu, A. Kossenkov, A. Keshavarzian, A. Landay, M. Abdel-Mohsen, Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients, Front. Immunol. 12 (2021) 1\u201316. https:\/\/doi.org\/10.3389\/fimmu.2021.686240.","DOI":"10.3389\/fimmu.2021.686240"},{"key":"10.1016\/j.biopha.2022.114050_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183279","article-title":"Molecular architecture and assembly of the tight junction backbone","volume":"1862","author":"Piontek","year":"2020","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.biopha.2022.114050_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2249.1999.00878.x","article-title":"Interferon-gamma (IFN-\u03b3)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice","volume":"116","author":"Obermeier","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2022.114050_bib58","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s10620-006-9644-9","article-title":"PPAR\u03b2\/\u03b4 protects against experimental colitis through a ligand-independent mechanism","volume":"52","author":"Hollingshead","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2022.114050_bib59","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41598-018-38125-x","article-title":"IL-10 produced by macrophages regulates epithelial integrity in the small intestine","volume":"9","author":"Morhardt","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.114050_bib60","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.18632\/oncotarget.8337","article-title":"IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine","volume":"7","author":"Girard-Madoux","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.114050_bib61","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/mi.2013.103","article-title":"IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis","volume":"7","author":"Li","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2022.114050_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1074-7613(00)80005-9","article-title":"Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of stat3 in macrophages and neutrophils","volume":"10","author":"Takeda","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.114050_bib63","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.immuni.2014.03.011","article-title":"Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function","volume":"40","author":"Shouval","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.114050_bib64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.172.1.567","article-title":"Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages","volume":"172","author":"Williams","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.114050_bib65","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1172\/JCI17085","article-title":"Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice","volume":"111","author":"Kobayashi","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2022.114050_bib66","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tem.2022.02.005","article-title":"A matter of time: temporal structure and functional relevance of macrophage metabolic rewiring","volume":"33","author":"Seim","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.114050_bib67","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.3748\/wjg.v26.i24.3365","article-title":"Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways","volume":"26","author":"Kamalian","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.114050_bib68","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/jcmm.17175","article-title":"Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease","volume":"26","author":"Baumann","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2022.114050_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2014.361","article-title":"Peroxisome proliferator-activated receptor \u03b1 activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway","volume":"5","author":"Jiao","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.114050_bib70","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.bjp.0707477","article-title":"PPAR\u03b1 agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages","volume":"152","author":"Paukkeri","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.114050_bib71","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4049\/jimmunol.161.2.978","article-title":"Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1","volume":"161","author":"Colville-Nash","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.114050_bib72","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","article-title":"Alternative M2 activation of kupffer cells by PPAR\u03b4 ameliorates obesity-induced insulin resistance","volume":"7","author":"Odegaard","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.114050_bib73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0710409","article-title":"Obstacles and opportunities for understanding macrophage polarization","volume":"89","author":"Murray","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2022.114050_bib74","article-title":"A randomized, placebo-controlled study of PPAR-alpha agonist fenofibrate in patients with nonalcoholic steatohepatitis (NASH)","volume":"50","author":"Conjeevaram","year":"2009","journal-title":"Hepatology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:06:32Z","timestamp":1778547992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222014391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":74,"alternative-id":["S0753332222014391"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114050","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elafibranor modulates ileal macrophage polarization to restore intestinal integrity in NASH: Potential crosstalk between ileal IL-10\/STAT3 and hepatic TLR4\/NF-\u03baB axes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114050"}}